Apyx Medical Corp Operating Lease Right-of-Use Assets
Apyx Medical Corp (APYX) had Operating Lease Right-of-Use Assets of $4.01 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-06
- 2026-06-30: Operating Lease, Right-of-Use Asset $4.01M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $4.09M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $4.22M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $4.34M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $4.01M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $4.09M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $4.22M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $4.34M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $4.46M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $4.58M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $4.70M 10-K · filed 2026-03-10 |
| 2024-09-30 | $4.82M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $4.93M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $5.05M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $5.16M 10-K · filed 2025-03-13 |
| 2023-09-30 | $5.27M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $5.42M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $646.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $710.00K 10-K · filed 2024-03-21 |
| 2022-09-30 | $774.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $659.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $90.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $121.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | $152.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $182.00K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $212.00K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $237.00K 10-K · filed 2022-03-17 |
| 2020-09-30 | $266.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $295.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $322.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $350.00K 10-K · filed 2021-03-31 |
| 2019-09-30 | $368.00K 10-Q · filed 2019-11-15 |
| 2019-03-31 | $178.00K 10-K · filed 2020-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |